The design of Senphonix is grounded in national research conducted with both frontline nurses and healthcare financial decision-makers. These studies provide rare alignment across clinical and financial perspectives.
Nurses described manual vitals as a task that consumes time without adding proportional clinical value. Many noted that continuous monitoring would allow them to focus on higher-level assessment and intervention, improving both patient safety and professional satisfaction.
Finance leaders echoed these findings from a system-level perspective. A strong majority indicated that recovery of nursing time was the most compelling driver of value. Readmission avoidance and RPM reimbursement followed closely, but only when solutions were predictable, secure, and low burden. Finance leaders consistently expressed skepticism toward technologies that shifted work rather than eliminating it.
In recent discussions with healthcare IT (information technology) professionals, another constrained resource in many organizations, simple implementations, ease of system integration and a lack of necessity to provide regular maintenance were key to adoption success.
This convergence of perspectives is notable. It suggests that automated monitoring addresses a shared pain point rather than a niche use case.
“This is not about replacing nursing judgment. It is about giving us the information early enough to use that judgment before a situation escalates.”
“What stood out to me is that nurses and finance are aligned on this. That almost never happens unless the problem is real.”
SleeveSense™ will be available upon FDA clearance, which is expected in early 2027.
Senphonix is a Delaware C-corp., with offices in Minnesota and Arizona. For more information, contact us at info@senphonix.com or 612-913-0607; or follow us on LinkedIn. Copyright © 2026 Senphonix, Inc. - All Rights Reserved. Logos and trademarks are the property of their respective owners. All quotes herein are drawn from anonymous responses to two MarketWise Advising ("MarketWise") national studies, commissioned by Senphonix; some quotes were lightly edited for brevity.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.